Uploaded by hannah.krier

Antidiabetic drugs

advertisement
Antidiabetic drugs
Differentiate between Type I & II diabetes
Type I
Insulin only (no oral)
Hereditary
Producing no insulin, not enough or ineffective
Diagnosed as a child
Skinny
No insulin so glucose cannot get into cell= hyperglycemia
Pump or SC injections
Type II
Most common
Caused by lifestyle
Reversible
Insulin resistance or deficiency
Need to decrease the insulin secretions
DKA- only regular insulin via IV
Identify normal blood glucose levels
Normal fasting <100 mg/dL
Identify values associated with hyperglycemia
Fasting plasma >126 mg/dL
Symptoms
Hot and dry
Identify values associated with hypoglycemia
Blood glucose <70 mg/dL
Symptoms
Cool and clammy, need some candy
Looks like they're drunk
Know what the Hgb A1C indicates, what is it? What does it indicate? Ranges for
diabetic/non-diabetic
Average daily blood glucose over past 3 months
Normal
4-5.9%
Diabetic diagnosis
>6.5%
Well controlled Type II
>7%
Discuss the function of insulin
Allows the cells in the muscles, fat and liver to absorb glucose that is in the blood.
Differentiate between the insulins regarding onset, peak, and duration of therapeutic
action, and names of the insulins
Rapid acting
Must be administered within 5 minutes before a meal
Prototype
Lispro (humalog)
Aspart (novolog)
Onset
15-30 minutes
Peak (most risk for hypoglycemia)
0.5-2.5 hours
Therapeutic duration
3-6 hours
Short acting (clear)
Given 30 minutes before a meal
Only given IV bolus, infusion, IM
Prototype
Regular insulin (humulin R)
Onset
30-60 minutes
Peak (most risk for hypoglycemia)
1-5 hours
Therapeutic duration
6-10 hours
Intermediate acting (cloudy)
Prototype
NPH (humulin N)
Onset
1-2 hours
Peak (most risk for hypoglycemia)
6-14 hours
Therapeutic duration
16-24 hours
Long acting
Administer once daily
Cannot be mixed**
Prototype
Glargine (lantus)
Onset
1 hour
Peak (most risk for hypoglycemia)
None
Therapeutic duration
24 hours
Identify why knowing when the insulins onset of action is important
Know when patient needs to eat
Identify why knowing when the insulins peak is important
Most risk for hypoglycemia
Discuss the causes, symptoms and treatment of hypoglycemia
Cool and clammy, need some candy
Looks like they're drunk
Describe the sliding scale insulin dosing, understand how to read it and utilize it
Regular insulin doses adjusted according to blood glucose
Discuss nursing implications of administering insulin – drawing up, rotating injection
sites, storage of, etc.
Check glucose before giving insulin
Roll vial instead of shaking to avoid bubbles
Ensure correct storage
Insulin only goes in insulin syringes
Ensure correct timing with insulin does with meals
Complete all rights
Double verification
Clear then cloudy
Provide education
Self administration
Timing of dose
Monitor blood glucoses
Injection site rotation
Know what the nurse needs to teach the patient about self- administration of insulin
Rotate sites
Differentiate between the different classifications of the oral antidiabetic agents
Sulfonylureas (Pancreas)
Stimulate insulin secretion from the beta cells of the pancreas, thus
increasing insulin levels
First generation
Prototype
Chlorpropamide (Diabinese)
Tolazamide (Tolinase)
Side effects
Hypoglycemia, hematologic effects, nausea, epigastric
fullness, heartburn, many others
Second generation
Prototype
Glipizide (Glucotrol)
Biguanides (Liver)
Decreased production of glucose by the liver by inhibiting
(gluconeogenesis)
Increases muscles glucose uptake and use
Prototype
Metformin (Glucophage)
Lactic Acidosis
Fatal. Look at ABGs (pH).
Risk increases with
Impaired liver or renal function
Alcoholism
S&S
Malaise, increasing somnolence
Myalgias
Hypotension
Bradyarrhythmias
Side effects
Abdominal bloating, metallic taste, nausea, cramping,
diarrhea, reduced vit B12
Meglitinides (Glinides)
Prototype
Repaglinide (Prandin)
Promote insulin release by pancreas
Prototype
Sitagliptin (Januvia)
Incretins “gliptins” DPP4 inhibitor
Lowers fasting and post meal blood glucose levels
Augments incretin hormones with promote release if insulin and
decrease secretion of glucagon
Prototype
Exenatide (Byetta)
Incretin mimetics GLP-1
May be used with metformin or a sulfonylurea
Glitazones
Alpha-glucosidase inhibitors (GI)
Slows carbohydrate absorption and digestion
Prototype
Acarbose (Precise)
Adverse Effects
Abdominal bloating, gas, diarrhea
Incretins
Thiazolidinediones
Enhances insulin action at the cell receptor site
Increase glucose uptake and use in skeletal muscle
Administered 1-2 times a day with food
Hypoglycemia does not occur
Adverse effects
Liver damage
Liver function test every 2-3 months
Promotes fluid retention.
Contraindicated for heart failure or pulmonary edema
Prototype
Pioglitazone (Actos)
Side effects
Moderate weight gain
Edema
Mild anemia
Hepatic toxicity
Identify the mechanism of action of each of the above classes
Know which of the above work by causing insulin release from the pancreas
Why is this important?
Each drug class has a side effect specific to that class – be able to identify them
Nursing implications regarding administration of the oral agents
Always check blood glucose levels
Usually given 30 minutes before meals
Alpha-glucosidase
inhibitors are given with the first bite of each main meal
Metformin
is taken with meals to reduce GI effects
Before giving any drugs that alter glucose levels
Assess the patient's ability to consume food
Assess for nausea and vomiting
Hypoglycemia may be a problem if antidiabetic agents are given and the
patients does not eat
overall concerns for any diabetic patient increase when the patient
Is under stress
Has an infection
Has an illness or trauma
Is pregnant
Monitor for A therapeutic response
Measure A1C to monitor long-term compliance to diet and drug therapy
Watch for hypoglycemia and hyperglycemia
Always determine LOC and ability to swallow
If hypoglycemia occurs
Give glucagon PRN
Have the patient eat glucose tablets or gel,m corn syrup, honey
Eat a small snack such as crackers or half a sandwich
Monitor blood glucose levels
Patient education
Disease process
Diet and exercise recommendations
Self administration of insulin or oral agents
Download